Elsevier

Surgery

Volume 117, Issue 5, May 1995, Pages 510-519
Surgery

Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma*

https://doi.org/10.1016/S0039-6060(05)80250-8Get rights and content

Background. We recently developed a novel system of direct hemoperfusion under hepatic venous isolation in an attempt to achieve high-dose intraarterial chemotherapy for patients with malignant liver tumors. We report here the results of treatment of these patients with advanced hepatocellular carcinoma.

Methods. Adriamycin (100 to 150 mg/m2) was administered into the hepatic artery of 15 patients, under conditions of extracorporeal drug elimination by direct hemoperfusion under hepatic venous isolation. Hepatic venous isolation was accomplished mainly by the double-balloon technique with an occlusion catheter and a balloon catheter. The isolated hepatic venous blood was filtered by direct hemoperfusion and pumped to the left axillary vein.

Results. During 5 minutes of adriamycin infusion, the mean drug extraction ratios of the direct hemoperfusion filters were 91%±9% (mean±SD). The amount of drug removed by the system was 26.4%±16.0% of the amount of drug administered. Two patients died, one of necrotizing pancreatitis and the other of hepatic arterial thrombosis. Both deaths were related directly to the hepatic arterial catheter. Other side effects included hemolysis related to the system of hemoperfusion (87%), chemical hepatitis (80%), leukopenia less than 3000/mm3 (67%), alopecia (33%), and nausea and vomiting (20%). Nine (64%) of 14 evaluable patients had objective tumor responses, with a median duration of response of 6.2 months.

Conclusions. This approach offers an effective therapeutic option for patients with advanced hepatocellular carcinoma.

References (25)

  • MulcareRJ et al.

    Isolation and perfusion of the liver for cancer chemotherapy

    J Surg Res

    (1973)
  • OkudaK et al.

    Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

    Cancer

    (1985)
  • NagasueN et al.

    Clinical experience with 118 hepatic resections for hepatocellular carcinoma

    Surgery

    (1986)
  • Primary liver cancer in Japan. Sixth report

    Cancer

    (1987)
  • SasakiY et al.

    Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma

    Ann Surg

    (1987)
  • KraybillWB et al.

    Regional intraarterial infusion of adriamycin in the treatment of cancer

    Surg Gynecol Obstet

    (1977)
  • BernMM et al.

    Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma

    Cancer

    (1978)
  • DociR et al.

    Intrahepatic chemotherapy for unresectable hepatocellualr carcinoma

    Cancer

    (1988)
  • BreedisC et al.

    The blood supply of neoplasms in the liver

    Am J Pathol

    (1954)
  • LienWM et al.

    The blood supply of experimental liver metastases

    Surgery

    (1970)
  • CadyB et al.

    Arterial infusion chemotherapy of hepatoma

    Surg Gynecol Obstet

    (1974)
  • WellwoodJM et al.

    Treatment of primary liver cancer: response to regional chemotherapy

    Clin Oncol (R Coll Radiol)

    (1979)
  • Cited by (33)

    • Percutaneous Pelvic Perfusion with Extracorporeal Chemofiltration for Advanced Uterine Cervical Carcinoma

      2008, Surgical Oncology Clinics of North America
      Citation Excerpt :

      Once vascular access established, an activating clotting time longer than 200 seconds was maintained with systemic heparinization. After anticoagulation, the specially designed inferior vena cava (IVC) occlusion balloon catheter (radiopaque, 60 cm long, 21 French, with a single balloon and three lumens; Sumitomo Bake Corporation, Ohtsu, Japan) [8] was introduced through the right femoral vein and was advanced under fluoroscopic guidance until the tip was beneath the renal vein. The balloon was then inflated with half-strength iodinated contrast at a rate of 4 to 6 mL.

    • Isolated Hepatic Perfusion for Extensive Liver Cancers

      2006, Surgery of the Liver, Biliary Tract and Pancreas: Volumes 1-2, Fourth Edition
    View all citing articles on Scopus
    *

    Supported in part by grants-in-aid for scientific research (0280721, 04670781, and 06454386) from the Ministry of Education, Science and Culture, Japan.

    View full text